Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McMaster University

$41,100.00

Theoretical study of ligand-receptor interactions in potassium channels

EF 2010-11

Résumé
Excitable cells in the brain, heart, nerves, muscle, and other organs and tissues change their functional state in response to electrical and chemical signals. These important physiological processes are controlled by ion channels, which enable fast and selective permeation of various ions across cell membranes. The crucial physiological role of ion channels has made them targets for deadly toxins synthesized by various organisms as attack or defense weapons. The human genome has 76 genes that encode potassium channel proteins, which are the most diverse group of ion channels. Mutations in some potassium channel genes cause severe inherited disorders such as cardiac arrhythmias. Potassium channel blockers are used for the treatment of diabetes, multiple sclerosis, psoriasis, and other autoimmune diseases. Some cardiovascular and neurological disorders are also treated with drugs, which target potassium channels. Understanding structure, dynamics, and pharmacology of potassium channels is important for basic knowledge and for designing new drugs. X-ray crystallography revealed atomic-resolution three-dimensional structures of several potassium channels in the open and closed states. These structures can be used in computer-based molecular modeling studies aimed to predict and visualize complexes of the channels with various drugs. In this project, powerful parallel computers and sophisticated software will be employed to predict binding sites of various drugs in several potassium channels, to simulate dynamics of the channel proteins and predict complexes of the channels with various drugs. The computer-generated molecular models will help better understand mechanisms of drug action in potassium channels. In collaboration with leading scientists in USA and Germany, the models will be experimentally verified and used to design new experiments. The study will provide information, which may help design new potent and selective drugs.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
238773-2009
Name nom
Zhorov, Boris
Department département
Biochemistry and Biomedical Sciences
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
41100
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5103
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell membranes
Research subject fr
Membranes cellulaires
Partie
2
Nb partie
5
Application title
Theoretical study of ligand-receptor interactions in potassium channels
Keyword
NSERC
Application summary
Excitable cells in the brain, heart, nerves, muscle, and other organs and tissues change their functional state in response to electrical and chemical signals. These important physiological processes are controlled by ion channels, which enable fast and selective permeation of various ions across cell membranes. The crucial physiological role of ion channels has made them targets for deadly toxins synthesized by various organisms as attack or defense weapons. The human genome has 76 genes that encode potassium channel proteins, which are the most diverse group of ion channels. Mutations in some potassium channel genes cause severe inherited disorders such as cardiac arrhythmias. Potassium channel blockers are used for the treatment of diabetes, multiple sclerosis, psoriasis, and other autoimmune diseases. Some cardiovascular and neurological disorders are also treated with drugs, which target potassium channels. Understanding structure, dynamics, and pharmacology of potassium channels is important for basic knowledge and for designing new drugs. X-ray crystallography revealed atomic-resolution three-dimensional structures of several potassium channels in the open and closed states. These structures can be used in computer-based molecular modeling studies aimed to predict and visualize complexes of the channels with various drugs. In this project, powerful parallel computers and sophisticated software will be employed to predict binding sites of various drugs in several potassium channels, to simulate dynamics of the channel proteins and predict complexes of the channels with various drugs. The computer-generated molecular models will help better understand mechanisms of drug action in potassium channels. In collaboration with leading scientists in USA and Germany, the models will be experimentally verified and used to design new experiments. The study will provide information, which may help design new potent and selective drugs.